CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 189 filers reported holding CARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $125,000 | -21.4% | 10,253 | -0.1% | 0.00% | – |
Q3 2021 | $159,000 | -14.5% | 10,266 | -21.4% | 0.00% | – |
Q2 2021 | $186,000 | -39.0% | 13,066 | -7.0% | 0.00% | – |
Q1 2021 | $305,000 | +45.9% | 14,051 | +1.9% | 0.00% | – |
Q4 2020 | $209,000 | +20.1% | 13,788 | +0.9% | 0.00% | – |
Q3 2020 | $174,000 | -29.6% | 13,661 | -5.5% | 0.00% | – |
Q2 2020 | $247,000 | +14.4% | 14,456 | -11.8% | 0.00% | – |
Q1 2020 | $216,000 | -37.4% | 16,381 | -23.4% | 0.00% | – |
Q4 2019 | $345,000 | -19.0% | 21,389 | -8.1% | 0.00% | -100.0% |
Q3 2019 | $426,000 | -19.5% | 23,285 | -5.3% | 0.00% | 0.0% |
Q2 2019 | $529,000 | -7.5% | 24,591 | -15.6% | 0.00% | 0.0% |
Q1 2019 | $572,000 | +294.5% | 29,153 | +161.2% | 0.00% | – |
Q4 2018 | $145,000 | -55.1% | 11,161 | -17.1% | 0.00% | – |
Q3 2018 | $323,000 | +29.2% | 13,471 | +3.1% | 0.00% | – |
Q2 2018 | $250,000 | +25.6% | 13,069 | -19.8% | 0.00% | – |
Q4 2017 | $199,000 | +15.0% | 16,293 | +44.9% | 0.00% | – |
Q2 2017 | $173,000 | – | 11,243 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,304,603 | $18,617,000 | 2.04% |
RHO CAPITAL PARTNERS INC | 1,499,058 | $21,392,000 | 1.96% |
DAFNA Capital Management LLC | 315,000 | $4,495,000 | 0.94% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 432,178 | $6,167,000 | 0.72% |
Altium Capital Management LP | 150,000 | $2,141,000 | 0.50% |
Cypress Capital Management LLC (WY) | 16,743 | $239,000 | 0.18% |
DISCIPLINED GROWTH INVESTORS INC /MN | 674,846 | $9,630,000 | 0.18% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 73,902 | $1,055,000 | 0.16% |
FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $28,540,000 | 0.12% |
FIRST QUADRANT LLC/CA | 71,223 | $1,016,000 | 0.12% |